As a bright young medical student at Makerere University, Andrew Kambugu thought he was destined to have to leave his home country of Uganda to pursue the training he needed to develop a career in infectious disease research and treatment. Instead, he was given the opportunity to pursue international-caliber training while staying in Uganda through a fellowship program at the Infectious Diseases Institute (IDI) in Kampala. That opportunity changed his life. Dr. Kambugu is now the new Sande-McKinnell Executive Director of the IDI.
Accordia Global Health Foundation, which merged with Africare in 2016, recognized the need for a major investment in healthcare capacity and stronger academic medical institutions in sub-Saharan Africa. In 2004, Accordia partnered with Makerere University and Pfizer Inc to establish IDI, a unique Ugandan institution that provides the highest standards of infectious disease care, and training and where international research is nurtured and conducted. Today, IDI covers almost 25% of the population for HIV treatment in Uganda, both directly and in partnership with government and non-government health facilities. Over 27,000 trainees from 27 African countries have graduated from the IDI Training Program in the areas of HIV/AIDS, malaria, research, and health systems strengthening. Graduates scatter across the continent, working in both the public and private sector, effectively shaping the health care system in the region. IDI concurrently runs 102 projects, and its research team has published over 600 papers in peer-reviewed journals, many of which have had a lasting impact on
policy and practice guidelines in the field of infectious diseases globally, regionally, and nationally.
IDI has contributed to the improved ranking of Makerere University as one of the top five research universities in Africa.
At IDI, Dr. Kambugu received high-quality specialized training and research time, supporting resources, and intensive mentorship needed to flourish in his field, while continuing to serve his home country and community. Soon after graduating from IDI's fellowship program in 2005, he distinguished himself from candidates from all over the world and was appointed Head of Clinical Services at IDI. In that position, he oversaw the cooperation between IDI and 10 public-sector clinics in the city of Kampala in a successful attempt to decongest the overwhelmed healthcare system in Uganda. He then turned his focus to the IDI research department, and became Head of Research in 2012. During his tenure as Head of Research he provided institutional oversight for many impactful research projects, including one that changed the international guideline of when to initiate antiviral treatment for patients with cryptococcal meningitis, a life-threatening fungal infection among HIV positive individuals.
Today, Dr. Kambugu is taking on full leadership of the IDI as Executive Director. His success and continued commitment to staying in his home country of Uganda is a testament to the remarkable return on investment that is possible by strengthening health institutions on the continent and investing in tomorrow's health leaders. "East or west, home is best," says Dr. Kambugu. Indeed, IDI provides healthcare professionals with training and opportunities previously unavailable in Africa. As a result, it retains valuable skills and develops expertise where they are needed most.